{"id":428906,"date":"2019-09-17T12:00:01","date_gmt":"2019-09-17T12:00:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=428906"},"modified":"2019-09-17T12:00:01","modified_gmt":"2019-09-17T12:00:01","slug":"china-antiobesity-prescription-drugs-market-research-report-2019","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/china-antiobesity-prescription-drugs-market-research-report-2019_428906.html","title":{"rendered":"China Anti-Obesity Prescription Drugs Market Research Report 2019"},"content":{"rendered":"
\"China<\/a><\/p>\n
\n
China Anti-Obesity Prescription Drugs Market <\/div>\n<\/div>\n<\/div>\n
The China Anti-Obesity Prescription Drugs market is valued at USD 55.20 million in 2018 and is expected to reach USD 72.53 million by the end of 2025, growing at a CAGR of 3.90% between 2019 and 2025.<\/p>\n<\/div>\n

This report studies the Anti-Obesity Prescription Drugs<\/a> development status and future trend in China, focuses on top players in China, also splits Anti-Obesity Prescription Drugs by type and by applications, to fully and deeply research and reveal the market general situation and future forecast. <\/p>\n

The China Anti-Obesity Prescription Drugs market is valued at USD 55.20 million in 2018 and is expected to reach USD 72.53 million by the end of 2025, growing at a CAGR of 3.90% between 2019 and 2025.<\/p>\n

Browse the report at –<\/strong> https:\/\/www.crystalmarketreport.com\/china-anti-obesity-prescription-drugs-market-research-report-2018\/<\/a><\/p>\n

The major players in global market include –
<\/strong><\/p>\n

Zhejiang Hisun<\/p>\n

ZHIEN pharmaceutica<\/p>\n

Lunan<\/p>\n

Wanhan<\/p>\n

Huadong Medicine<\/p>\n

Roche<\/p>\n

Other<\/p>\n

Geographically, this report splits the China market into seven regions –
<\/strong><\/p>\n

South China<\/p>\n

East China<\/p>\n

Southwest China<\/p>\n

Northeast China<\/p>\n

North China<\/p>\n

Central China<\/p>\n

Northwest China <\/p>\n

Read full details of Table of contents –<\/strong> https:\/\/www.crystalmarketreport.com\/china-anti-obesity-prescription-drugs-market-research-report-2018\/toc<\/a><\/p>\n

On the basis of product, the Anti-Obesity Prescription Drugs market is primarily split into –
<\/strong><\/p>\n

OTC<\/p>\n

Rx <\/p>\n

On the basis on the end users\/applications, this report covers –
<\/strong><\/p>\n

Hospitals Pharmacies<\/p>\n

Retail Pharmacies<\/p>\n

E-commerce<\/p>\n

Request free sample –<\/strong> https:\/\/www.crystalmarketreport.com\/sample\/211028<\/a><\/p>\n

Table of Contents:<\/strong><\/p>\n

1 Anti-Obesity Prescription Drugs Overview 1<\/p>\n

2 China Anti-Obesity Prescription Drugs Market Competition by Players\/Manufacturers 22<\/p>\n

3 China Anti-Obesity Prescription Drugs Sales and Revenue by Regions (2014-2019) 32<\/p>\n

4 China Anti-Obesity Prescription Drugs Sales and Revenue by Type\/ Product Category (2014-2019) 37<\/p>\n

5 China Anti-Obesity Prescription Drugs Sales by Application (2014-2019) 42<\/p>\n

6 Analysis of Anti-Obesity Prescription Drugs Industry Key Manufacturers 45<\/p>\n

6.1 Zhejiang Hisun 45<\/p>\n

6.2 ZHIEN pharmaceutica 47<\/p>\n

6.3 Lunan 49<\/p>\n

6.4 Wanhan 51<\/p>\n

6.5 Huadong Medicine 53<\/p>\n

6.6 Roche 55<\/p>\n

7 Anti-Obesity Prescription Drugs Manufacturing Cost Analysis 57<\/p>\n

8 Industrial Chain, Sourcing Strategy and Downstream Buyers 63<\/p>\n

9 Marketing Strategy Analysis, Distributors\/Traders 66<\/p>\n

10 Factors Influencing 73<\/p>\n

10.1 Price Trend of Key Industrial Raw Material 73<\/p>\n

10.2 Imports & Exports 74<\/p>\n

11 China Anti-Obesity Prescription Drugs Market Size (Sales and Revenue) Forecast (2020-2025) 80<\/p>\n

12 Research Findings and Conclusion 86<\/p>\n

13 Methodology and Data Source 87<\/p>\n

Read full details of Table of contents –<\/strong> https:\/\/www.crystalmarketreport.com\/china-anti-obesity-prescription-drugs-market-research-report-2018\/toc<\/a> <\/p>\n

About Us:<\/strong><\/p>\n

Crystal Market Reports is a distributor of market research spanning 160 industries. Our extensive database consists of over 200,000 quality publications sourced from 400 plus publishers, this puts our research specialists in the unique position of been able to offer truly unbiased advice on what research provides the most valuable insights.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Crystal Market Reports <\/a>
Contact Person:<\/strong> Tom Sam
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 1-518-730-0564
Address:<\/strong>90 State Street, Suite 700
City:<\/strong> Albany
State:<\/strong> New York 12207
Country:<\/strong> United States
Website:<\/strong> www.crystalmarketreport.com\/china-anti-obesity-prescription-drugs-market-research-report-2018<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

China Anti-Obesity Prescription Drugs Market The China Anti-Obesity Prescription Drugs market is valued at USD 55.20 million in 2018 and is expected to reach USD 72.53 million by the end of 2025, growing at a CAGR of 3.90% between 2019 … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,411,404],"tags":[],"class_list":["post-428906","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Technology","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/428906","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=428906"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/428906\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=428906"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=428906"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=428906"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}